News Quantified

ANIK – anika therapeutics inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Are Investors Undervaluing Anika Therapeutics, Inc. (NASDAQ:ANIK) By 39%? [Yahoo! Finance]

Anika Therapeutics (NASDAQ:ANIK) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Anika Therapeutics (NASDAQ:ANIK) had its price target raised by analysts at Barrington Research from $15.00 to $16.00. They now have an "outperform" rating on the stock.

Anika Reports Third Quarter 2025 Financial Results

Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study

1.0%

BEAT

-34.8%

BEAT

-14.7%

BEAT

-11.1%

BEAT

Barrington Research

Barrington Research

Barrington Research

Form SCHEDULE 13D/A Anika Therapeutics, Inc. Filed by: Caligan Partners LP

Form SCHEDULE 13G/A Anika Therapeutics, Inc. Filed by: Trigran Investments, Inc.

Form S-8 Anika Therapeutics, Inc.

Form 10-Q Anika Therapeutics, Inc. For: Sep 30

Form 8-K Anika Therapeutics, Inc. For: Nov 05

Top News Gainers

10/24 Q3/2019 9/30/2019 EPS 0.640 ZacksConsensus 0.410 ActVsEst 0.230 - Beat 35.2%

7/24 Q2/2019 6/30/2019 EPS 0.670 ZacksConsensus 0.420 ActVsEst 0.250 - Beat 29.0%

4/8 Anika Therapeutics beefs up liquidity amid COVID-19 disruptions [Seeking Alpha] 9.0%

3/24 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.9%

4/28 Form 4 Anika Therapeutics, Inc. For: Apr 26 Filed by: Blanchard Cheryl R 7.9%

5/3 Anika Therapeutics, Inc. 2019 Q1 - Results - Earnings Call Slides [Seeking Alpha] 5.9%

1/6 Anika Therapeutics to Acquire Parcus Medical and Arthrosurface 4.6%

4/22 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.6%

4/27 Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer 4.3%

7/25 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $46.00 price target on the stock. 3.2%

Top News Decliners

3/13 Form 8-K/A Anika Therapeutics, Inc. For: Feb 03 -16.2%

3/18 Form SEC STAFF LETTER Anika Therapeutics, Inc. -11.5%

3/6 Form 3 Anika Therapeutics, Inc. For: Mar 04 Filed by: Colleran David -9.4%

4/29 Form DEF 14A Anika Therapeutics, Inc. For: Jun 16 -7.3%

2/20 Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.0%

3/17 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -5.8%

1/29 Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer -5.4%

4/27 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock. -4.7%

7/26 Anika Therapeutics Inc (NASDAQ: ANIK) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -4.5%

7/30 Anika Therapeutics Inc (NASDAQ: ANIK) was upgraded by analysts at TheStreet from a "c" rating to a "b-" rating. -4.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day